CATEGORY PERFORMANCE: INTERNAL ANALGESICS

Dollar Sales $967,273,100: % Change From Last Year -3.27ue source for supermarkets. The category contributed just over $2 billion in the food, drug and mass channels during the 52 weeks ended June 13. Dollar sales for food, drug and mass have declined slightly since 2002, creeping down 1% or 2% each year.Of that figure, $967.3 million was spent in supermarkets. However, that number shows a 3.27% decline

Dollar Sales $967,273,100: % Change From Last Year -3.27

ue source for supermarkets. The category contributed just over $2 billion in the food, drug and mass channels during the 52 weeks ended June 13. Dollar sales for food, drug and mass have declined slightly since 2002, creeping down 1% or 2% each year.

Of that figure, $967.3 million was spent in supermarkets. However, that number shows a 3.27% decline in dollar sales for the category. Dollar sales of internal analgesics declined 1.86% in calendar year 2003, and prior to that declined 3.65% in 2002.

The majority of internal analgesic sales came from tablets, which accounted for $857.5 million for the most recent 52 weeks, a decline of 3.19%. Analgesic liquids had sales of $88.4 million for the same time period, a decline of 2.14%. Feminine pain relievers experienced the largest drop within the category, falling 10.58% to $21.4 million in dollar sales for the most recent 52-week period.

The drug channel, by comparison, has grown its dollar sales marginally each year: 3.2% in 2003 and 3.43% in 2002. Drug stores marginally dominated the category with just over a billion in sales for both those time frames.

Subcategories: 52-week sales; % change

INTERNAL ANALGESIC TABLETS: $857,487,000; -3.19

INTERNAL ANALGESIC LIQUIDS: $88,405,950; -2.14

FEMININE PAIN RELIEVERS: $21,380,140; -10.58

Latest 52 weeks ended June 13, 2004.

Dollar Sales Latest 52 Weeks Ended June 13, 2004; % Change; Dollar Sales Calendar Year Ended Dec. 28, 2003; % Change; Dollar Sales Calendar Year Ended Dec. 29, 2002; % Change

Supermarkets: $967,273,100; -3.27 $997,238,400; -1.86; $1,016,130,000; -3.65

Drug: $1,020,246,000; 0.14; $1,043,032,000; 3.20; $1,010,648,000; 3.43

F/D/MX: $2,199,688,000; -2.15 $2,261,083,000; -0.19; $2,265,360,000; -1.12